Status:
TERMINATED
A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection
Lead Sponsor:
Mayo Clinic
Conditions:
Covid19
Eligibility:
All Genders
18-89 years
Brief Summary
The purpose of this study is to assess the ability of an artificial intelligence smartphone-enabled point of care ECG to detect COVID-19.
Eligibility Criteria
Inclusion
- Adult males and females age 18 or greater.
- Undergoing COVID-19 testing by PCR.
- Willing and able to provide informed consent.
- Pregnant females (minimal risk study, no risk from ECG).
Exclusion
- \- Unwilling or unable to provide informed consent.
Key Trial Info
Start Date :
December 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 3 2021
Estimated Enrollment :
2821 Patients enrolled
Trial Details
Trial ID
NCT04725097
Start Date
December 10 2020
End Date
June 3 2021
Last Update
September 9 2021
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Phoenix, Arizona, United States, 85054
2
Mayo Clinic
Jacksonville, Florida, United States, 32224
3
LSUHSC Shreveport
Shreveport, Louisiana, United States, 71103
4
Henry Ford Health System
West Bloomfield, Michigan, United States, 48322